When compared to benign tissue, IL-6 expression was 10 fold greater in the CD49f−CD24−(MM) population, but significantly lower in the CD49f−CD24+(MP) (1-104 fold) and CD49f+CD24+(PP) populations (5-106 fold) (Figure 5C). This evidence concerns the gene CD24 and Miyoshi myopathy.